Trial ID or NCT#

NCT01462292

Status

NOT RECRUITING

Purpose

The purpose of this study is to determine if GSK2402968 is effective in the treatment of ambulant boys with Duchenne muscular dystrophy resulting from a mutation thought to be corrected by exon 51 skipping. Two doses of GSK2402968 and placebo will be used in this study.

Official Title

An Exploratory Study to Assess Two Doses of GSK2402968 in the Treatment of Ambulant Boys With Duchenne Muscular Dystrophy

Eligibility Criteria

Ages Eligible for Study: Older than 5 Years
Sexes Eligible for Study: Male
Accepts Healthy Volunteers: No

Investigator(s)

Yuen So, MD, PhD
Neuromuscular neurologist, Neurophysiologist
Professor of Neurology at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Shirley Paulose
650-724-3792